Skip to main content

MoneyWorks4Me

Ajanta gets listed in Forbes Asia's '200 Best under Billion' 2014

19 Aug 2014 Evaluate

Ajanta Pharma, a specialty focused pharmaceutical formulation company, has been listed on Forbes Asia's 'Best Under a Billion' 2014 list. This is the third consecutive listing of the company since 2012.

The ‘Best Under  A Billion’ list is published by Forbes Asia to recognize 200 small and midsized publicly listed companies in Asia Pacific region with annual revenue under $1 billion. The companies were selected based on three stringent categories of profitability, growth, and modest indebtedness from a universe of 17,000 stock-traded companies across Asia-Pacific region.

Ajanta Pharma is engaged in manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Peers
Company Name CMP
Sun Pharma. Inds. 1873.60
Dr. Reddys Labs. 1369.60
Cipla 1394.70
Lupin 1971.00
Zydus Lifesciences 1203.05
View more..